Insulinlike growth factor I and the kidney

Trends in Endocrinology and Metabolism

Volumn 7, Issue 3, 1996, Pages 85-93

  Feld, Stella ^a   Hirschberg, Raimund ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; NITRIC OXIDE; PHOSPHATE; PROTEINASE; RECOMBINANT SOMATOMEDIN C; SODIUM; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ACUTE KIDNEY TUBULE NECROSIS; ARTERY DILATATION; CREATININE CLEARANCE; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; KIDNEY PLASMA FLOW; KIDNEY TUBULE ABSORPTION; NEPHRON; NEPHROTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029924207     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/1043-2760(96)00009-4     Document Type: Short Survey

References (71)

1. Andersson GL, Skottner A, Jennische E: 1988. Immunocytochemical and biochemical localization of insulin-like growth factor I in the kidney of rats before and after uninephrectomy. Acta Endocrinol (Copenh) 119: 555-560.
2. Andersson GL, Ericson LE, Jennische E: 1990. Ultrastructural localization of IGF-I in the rat kidney; an immunocytochemical study. Histochemistry 94:263-267.
3. Bergenstal D, Lipsett M: 1960. Metabolic effects of human growth hormone and growth hormone of other species in man. J Clin Endocrinol Metab 20:1424-1436.
4. Blat C, Villaudy J, Binoux M: 1994. In-vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. J Clin Invest 93:2286-2290.
5. Blum W, Ranke M, Kietzmann K, Tonshoff B, Mehls O: 1989. Excess of IGF-binding protein in chronic renal failure: evidence for relative growth hormone resistance and inhibition of somatomedin activity. In Drop S, Hintz R, eds. Insulin-like Growth Factor Binding Proteins. Basel, Elsevier Science, pp 93-98.
6. Bonjour J, Caverzasio J: 1991. IGF-I a key controlling element in phosphate homeostasis during growth. In Spencer E, ed. Modern Concepts of Insulin-like Growth Factors. New York, Elsevier, pp. 193-198.
7. Caverzasio J, Bonjour JP: 1992. Tyrosine phosphorylation selectively regulates renal cellular phosphate transport: evidence that it mediates the stimulatory effect of insulin-like growth factor-1. Endocrinology 130:373-380.
8. Chin E, Bondy C: 1992. Insulin-like growth factor system gene expression in the human kidney. J Clin Endocrinol Metab 75:962-968.
9. Chin E, Zhou J, Bondy C: 1992a. Anatomical relationships in the patterns of insulin-like growth factor (IGF)-I, IGF binding protein-1, and IGF-I receptor gene expression in the rat kidney. Endocrinology 130:3237-3245.
10. Chin E, Zhou J, Bondy CA: 1992b. Renal growth hormone receptor gene expression: relationship to renal insulin-like growth factor system. Endocrinology 131:3061-3066.
11. Chin E, Michels K, Bondy CA: 1994a. Partition of insulin-like growth factor (IGF)-binding sites between the IGF-I and IGF-II receptors and IGF-binding proteins in the human kidney. J Clin Endocrinol Metab 78:156-164.
12. Chin E, Zhou J, Dai J, Baxter RC, Bondy CA: 1994b. Cellular localization and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complex. Endocrinology 134:2498-2504.
13. Christiansen JS, Gammelgaard J, Orskov H, et al.: 1981. Kidney function and size in normal subjects before and during growth hormone administration for one week. Eur J Clin Invest 11:487-490.
14. Clemmons DR, Jones JI, Busby WH, Wright G: 1993. Role of insulin-like growth factor binding proteins in modifying IGF actions. Ann NY Acad Sci 692:10-21.
15. Conti FG, Striker LJ, Elliot SJ, Andreani D, Striker GE: 1988. Synthesis and release of insulinlike growth factor I by mesangial cells in culture. Am J Physiol 255:F1214-F1219.
16. Conti FG, Elliot SJ, Striker LJ, Striker GE: 1989. Binding of insulin-like growth factor-I by glomerular endothelial and epithelial cells: further evidence for IGF-I action in the renal glomerulus. Biochem Biophys Res Commun 163:952-958.
17. Corvilain J, Abramow M, Bergans A: 1962. Some effects of human growth hormone on renal hemodynamics and on tubular phosphate transport in man. J Clin Invest 41: 1230-1235.
18. D'Ercole A, Underwood LE: 1987. Estimation of tissue concentrations of somatomedin C/insulin-like growth factor I. Methods Enzymol 146:227-233.
19. Ding H, Kopple JD, Cohen A, Hirschberg R: 1993. Recombinant human insulin-like growth factor-I accelerates recovery and reduces catabolism in rats with ischemic acute renal failure. J Clin Invest 91:2281-2287.
20. Doi T, Striker LJ, Quaife C, et al.: 1988. Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulinlike growth factor-1. Am J Pathol 131:398-403.
21. El Nahas AM, Le Carpentier JE, Bassett AH, Hill DJ: 1989. Dietary protein and insulin-like growth factor-I content following unilateral nephrectomy. Kidney Int Suppl 27: S15-S19.
22. Fagin JA, Melmed S: 1987. Relative increase in insulin-like growth factor I messenger ribonucleic acid levels in compensatory renal hypertrophy. Endocrinology 120:718-724.
23. Feld S, Hirschberg R, Artishevsky A, Nast C, Adler S: 1995. Insulin-like growth factor I induces mesangial proliferation and increases mRNA and secretion of collagen. Kidney Int 48:45-51.
24. Flyvbjerg A, Orskov H, Nyborg K, et al.: 1991. Kidney IGF-I accumulation occurs in four different conditions with rapid initial kidney growth in rats. In Spencer E, ed. Modern Concepts of Insulin-like Growth Factors. New York, Elsevier, pp 207-217.
25. Fogo A, Ichikawa I: 1991. Evidence for a pathogenic linkage between glomerular hypertrophy and sclerosis. Am J Kidney Dis 17:666-669.
26. Fouque D, Peng SC, Kopple JD: 1995a. Impaired metabolic response to recombinant insulin-like growth factor-1 in dialysis patients. Kidney Int 47:876-883.
27. Fouque D, Peng SC, Kopple JD: 1995b. Pharmacokinetics of recombinant human insulin-like growth factor-1 in dialysis patients. Kidney Int 47:869-875.
28. Franklin S, Moulton M, Hammerman M, Miller S: 1995. Sustained improvement of renal function and amelioration of symptoms in patients with chronic renal failure (CRF) treated with insulin-like growth factor I (IGF I) [abst]. J Am Soc Nephrol 6:387.
29. Frystyk J, Skjaerbaek C, Dinesen B, Orskov H: 1994. Free insulin like growth factor (IGF-I and IGF-II) in human serum. FEBS Lett 348:185-191.
30. Gallego M, Chai Q, Marrero M, Ling B: 1995. Stimulation of Na channels by IGF-I in A6 cells: possible role of tyrosine phosphorylation [abst]. J Am Soc Nephrol 6:337.
31. Garin E, Grant M, Silverstein J: 1989. Insulin-like growth factors in patients with active nephrotic syndrome. Am J Dis Child 143: 865-867.
32. Guler HP, Eckardt KU, Zapf J, Bauer C, Froesch ER: 1989a. Insulin-like growth factor I increases glomerular filtration rate and renal plasma flow in man. Acta Endocrinol (Copenh) 121:101-106.
33. Guler HP, Schmid C, Zapf J, Froesch ER: 1989b. Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects. Proc Natl Acad Sci USA 86:2868-2872.
34. Guler HP, Zapf J, Scheiwiller E, Froesch ER: 1988. Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci USA 85:4889-4893.
35. Hammerman MR, Rogers S: 1987. Distribution of IGF receptors in the plasma membrane of proximal tubular cells. Am J Physiol 253:F841-F847.
36. Haylor J, Singh I, El Nahas AM: 1991. Nitric oxide synthesis inhibitor prevents vasodilation by insulin-like growth factor I. Kidney Int 39:333-335.
37. Hirschberg R: 1993a. Effects of growth hormone and IGF-I on glomerular ultrafiltration in growth hormone-deficient rats. Regul Pept 48:241-250.
38. Hirschberg R: 1993b. IGF-I is ultrafiltered into the urinary space and may exert biological effects in proximal tubules in the nephrotic syndrome [abst]. J Am Soc Nephrol 4:771.
39. Hirschberg R, Kaysen GA: 1995. Insulin-like growth factor I and its binding proteins in the experimental nephrotic syndrome. Endocrinology 136:1565-1571.
40. Hirschberg RR, Kopple JD: 1988. Increase in renal plasma flow and glomerular filtration rate during growth hormone treatment may be mediated by insulin-like growth factor I. Am J Nephrol 8:249-254.
41. Hirschberg R, Kopple JD: 1989. Evidence that insulin-like growth factor I increases renal plasma flow and glomerular filtration rate in fasted rats. J Clin Invest 83:326-330.
42. Hirschberg R, Kopple JD: 1991. Response of insulin-like growth factor I and renal hemodynamics to a high- and low-protein diet in the rat. J Am Soc Nephrol 1:1034-1040.
43. Hirschberg R, Kopple JD: 1992. The growth hormone-insulin-like growth factor I axis and renal glomerular function. J Am Soc Nephrol 2:1417-1422.
44. Hirschberg R, Rabb H, Bergamo R, Kopple JD: 1989. The delayed effect of growth hormone on renal function in humans. Kidney Int 35:865-870.
45. Hirschberg R, Kopple JD, Blantz RC, Tucker BJ: 1991. Effects of recombinant human insulin-like growth factor I on glomerular dynamics in the rat. J Clin Invest 87:1200-1206.
46. Hirschberg R, Brunori G, Kopple JD, Guler HP: 1993. Effects of insulin-like growth factor I on renal function in normal men. Kidney Int 43:387-397.
47. Hirschberg R, Ding H, Wanner C: 1995. Effects of insulin-like growth factor I on phosphate transport in cultured proximal tubule cells. J Lab Clin Med 126:428-434.
48. Hodson E, Brown A, Roy L, Rosenberg A: 1992. Insulin-like growth factor-1, growth hormone-dependent insulin-like growth factor-binding protein and growth in children with chronic renal failure. Pediatr Nephrol 6:433-438.
49. Holly J: 1993. Insulin-like growth factor binding proteins in diabetic and non-diabetic states. In Flyvbjerg A, Orskov H, Alberti K, eds. Growth Hormone and Insulin-like Growth Factor I in Human and Experimental Diabetes. Chichester, UK, John Wiley & Sons, pp 47-76.
50. Inishi Y, Okuda T, Arakawa T, Kurokawa K: 1994. Insulin attenuates intracellular calcium responses and cell contraction caused by vasoactive agents. Kidney Int 45:1318-1325.
51. Jabri N, Schalch DS, Schwartz SL, et al.: 1994. Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients. Diabetes 43:369-374.
52. Jones JI, Clemmons DR: 1995. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34.
53. Kobayashi S, Clemmons DR, Venkatachalam MA: 1991. Colocalization of insulin-like growth factor-binding protein with insulin-like growth factor I. Am J Physiol 261:F22-F28.
54. Kobayashi S, Clemmons DR, Nogami H, Roy AK, Venkatachalam MA: 1995. Tubular hypertrophy due to work load induced by furosemide is associated with increases of IGF-1 and IGFBP-1. Kidney Int 47:818-828.
55. Kopple JD, Ding H, Gao XL: 1995. Altered physiology and action of insulin-like growth factor 1 in skeletal muscle in chronic renal failure. Am J Kidney Dis 26:248-255.
56. Landau D, Chin E, Bondy C, et al.: 1995. Expression of insulin-like growth factor binding proteins in the rat kidney: effects of long-term diabetes. Endocrinology 136:1835-1842.
57. Lee P, Hintz R, Sperry J, Baxter R, Powell D: 1989. IGF binding proteins in growth-retarded children with chronic renal failure. Pediatr Nephrol 5:539-544.
58. Matejka GL, Jennische E: 1992. IGF-I binding and IGF-I mRNA expression in the post-ischemic regenerating rat kidney. Kidney Int 42:1113-1123.
59. Matejka GL, Eriksson PS, Carlsson B, Jennische E: 1992. Distribution of IGF-I mRNA and IGF-I binding sites in the rat kidney. Histochemistry 97:173-180.
60. Miller SB, Hansen VA, Hammerman MR: 1990a. Effects of growth hormone and IGF-I on renal function in rats with normal and reduced renal mass. Am J Physiol 259: F747-F751.
61. Miller SB, Rotwein P, Bortz JD, et al: 1990b. Renal expression of IGF I in hypersomatotropic states. Am J Physiol 259:F251-F257.
62. Miller SB, Moulton M, Hammerman MR: 1994. Effects of IGF-I on renal function in end-stage chronic renal failure. Kidney Int 46:201-207.
63. Mulroney SE, Haramati A, Roberts CT, Jr., LeRoith D: 1991. Renal IGF-1 mRNA levels are enhanced following unilateral nephrectomy in immature but not adult rats. Endocrinology 128:2660-2662.
64. O'Shea M, Miller SB, Hammerman MR: 1993. Effects of IGF-I on renal function in patients with chronic renal failure. Am J Physiol 264:F917-F922.
65. Parving H, Noer I, Mogensen C, Svendsen P: 1978. Kidney function in normal man during short-term growth hormone infusion. Acta Endocrinol (Copenh) 89:796-800.
66. Powell D, Rosenfeld R, Sperry J, Baker B, Hintz R: 1987. Serum concentrations of insulin-like growth factor (IGF)-1, IGF-2 and unsaturated somatomedin carrier proteins in children with chronic renal failure. Am J Kidney Dis 4:287-292.
67. Quigley R, Baum M: 1991. Effects of growth hormone and insulin-like growth factor I on rabbit proximal convoluted tubule transport. J Clin Invest 88:368-374.
68. Schimpff RM, Donnadieu M, Duval M: 1980. Serum somatomedin activity measured as sulphation factor in peripheral, hepatic and renal veins of mongrel dogs: basal levels. Acta Endocrinol (Copenh) 93:67-72.
69. Shimasaki S, Ling N: 1991. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5, and -6). Progr Growth Factor Res 3:243-266.
70. Tsukahara H, Gordienko DV, Tonshoff B, Gelato MC, Goligorsky MS: 1994. Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. Kidney Int 45:598-604.
71. Young SC, Miles MV, Clemmons DR: 1992. Determination of the pharmacokinetic profiles of insulin-like growth factor binding proteins-1 and -2 in rats. Endocrinology 131:1867-1873. TEM